Academic plastic surgery training depends upon open access to learning reconstructive techniques provided by free vascularized soft tissue coverage. Key components of this approach include recruitment of an accomplished and diverse faculty, broad-based collaboration, patient geographic outreach, and fundamental support from all levels of staff. This study reviews a 10-year experience of microsurgical procedures and illustrates a successful framework for building a harmonized microsurgery team.
METHODS:
A 10-year retrospective institutional review was performed for FY [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] . Microsurgical flap type, operative volume, and outcomes were measured across all microsurgery faculty and participating hospitals. Microvascular compromise and flap salvage rates were noted for the six highest volume surgeons, accounting for 97% of all free flap cases.
RESULTS:
The 5000 th flap was performed in December, 2015 within this institutional study period. Of the 6 highest volume surgeons, 4,847 free flaps were examined for microvascular compromise, with an institutional mean takeback rate of 1.53% across 4 participating hospitals. Overall, 74.4% flaps performed were breast flaps, and the remainder were upper/lower extremity and head/neck flaps.
CONCLUSION:
With focused faculty and trainee recruitment, this institution has built the largest clinically productive academic microsurgical program in the country. Collaboration among faculty, staff and residents, all contribute to continual learning, innovation, and quality patient care. This established framework offers a workable and reproducible model in any metropolitan area within the US. PURPOSE: Current therapies for infantile hemangiomas (IH) have high risk side effect profiles. A proprietary blend of natural berry extracts (NBE) was studied as a possible alternative. Using a validated murine model we have shown that tumor forming endothelial (EOMA) cells escape cell death through induction of multidrug resistance protein 1 (MRP1) to efflux oxidized glutathione out of the nucleus. We sought to determine whether NBE could inhibit MRP1 to induce EOMA cell death and promote tumor involution.
NATURAL BERRY EXTRACTS AS A TREATMENT FOR HEMANGIOMAS

METHODS:
Calcein exclusion was used to measure MRP1 activity in NBE treated (50 ug/ml) EOMA cells. Oxidized and reduced glutathione were measured in subcellular fractions of NBE treated EOMA cells. NBE induced EOMA cell death was measured in vitro and in vivo using immunocytochemistry for activated Bax, Caspase 9 and cleaved Caspase 3. Mice were given a subcutaneous injection of NBE treated EOMA cells (5 x 10 6 cell/100 ul) to examine effects on tumor growth in vivo.
RESULTS:
NBE treatment significantly inhibited MRP1 activity and nuclear localization. This resulted in accumulation of oxidized glutathione in the nucleus with activation of the intrinsic apoptotic pathway as shown by significantly elevated Bax, Caspase 9 and cleaved Caspase 3. Mice injected with NBE treated EOMA cells developed smaller tumors in vivo with increased intrinsic apoptosis.
CONCLUSION:
This is the first report that NBE inhibits MRP1 resulting in decreased tumor size. MRP1 is overexpressed in many different types of tumors. Thus, NBE may have applications for treatment of IH and many other tumors. PURPOSE: Skin expansion is a commonly used method for harvesting extra skin tissue for reconstruction. However, the outcome of skin expansion can be unpredictable. Therefore, our goal is to develop a scoring system that can predict the regenerative capacity of expanded skin.
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